ResMed Inc. (RMD) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Resmed Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.219 Greetings, and welcome to the Q3 fiscal year 2025 ResMed 00:00:05.219 -- 00:00:10.366 earnings conference call. My name is Kevin, and I'll be your operator for today's call. 00:00:10.366 -- 00:00:14.051 At this time, all participants are in listening-only mode, and also please note this 00:00:14.051 -- 00:00:16.375 conference call is being recorded. 00:00:16.375 -- 00:00:19.579 Later, we'll conduct a question-and-answer session. 00:00:19.579 -- 00:00:24.186 Let me hand the call over to ResMed's chairman and CEO, Mick Farrell, for a brief introduction 00:00:24.186 -- 00:00:29.033 of Sally Schwartz, who recently joined the company as Chief Investor Relations Officer. 00:00:29.033 -- 00:00:30.946 Mick, please go ahead. 00:00:30.946 -- 00:00:36.011 Thank you, Kevin. I'm very excited to have Sally join the ResMed team, our newest 00:00:36.011 -- 00:00:37.493 ResMedian. 00:00:37.493 -- 00:00:41.938 She joined us earlier this week and brings more than two decades of experience across 00:00:41.938 -- 00:00:45.922 capital markets, healthcare, and technology. 00:00:45.922 -- 00:00:50.507 We look forward to Sally helping us to take investor relations to the next level here 00:00:50.507 -- 00:00:55.793 at ResMed, providing clarity, transparency, and long-term alignment amongst 00:00:55.793 -- 00:01:00.190 current and future investors and all of our stakeholders. 00:01:00.190 -- 00:01:02.613 So Sally, we're thrilled to have you on board. 00:01:02.613 -- 00:01:07.919 Thanks, Nick. I'm happy to be here and I look forward to meeting our investors very soon. 00:01:07.919 -- 00:01:12.925 But first, I want to welcome our listeners to ResMed's third quarter fiscal year 2025 00:01:12.925 -- 00:01:18.111 earnings call. We are live webcasting this call a...